Pharma, Biotech Patenting Down, Lawsuits Up, Survey Finds

Law360, New York (July 19, 2005, 12:00 AM EDT) -- Biotech and pharmaceutical patent litigation is continuing at a brisk pace, even though patenting has been slowing down since the beginning of the decade, according to a new report by Finnegan Henderson.

Patent litigation has continued at a modest, steady increase, a likely reflection of the continued recognition of the increased value of intellectual property assets. Biotech and pharmaceutical patent litigation appear consistent with this trend, according to the report.

The study found that the number of biotech and pharmaceutical cases at U.S. district courts and...
To view the full article, register now.